These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Annual meeting of the New Clinical Drug Evaluation Units (NCDEU) program, Psychopharmacology Research Branch, National Institute of Mental Health, 23-25 May 1978, Key Biscayne, Florida. Psychopharmacol Bull; 1979 Jul; 15(3):22-44. PubMed ID: 493456 [No Abstract] [Full Text] [Related]
4. Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder: Design, Definitions, and Ongoing Challenges for Child and Adolescent Psychopharmacology Research. Strawn JR; Croarkin PE J Child Adolesc Psychopharmacol; 2018 Jun; 28(5):363. PubMed ID: 29620924 [No Abstract] [Full Text] [Related]
5. Emerging drugs for major depressive disorder: an update. Rizvi SJ; Kennedy SH Expert Opin Emerg Drugs; 2012 Sep; 17(3):285-94. PubMed ID: 22530790 [No Abstract] [Full Text] [Related]
6. Antidepressant Treatment Duration in Pediatric Depressive and Anxiety Disorders: How Long is Long Enough? Hathaway EE; Walkup JT; Strawn JR Curr Probl Pediatr Adolesc Health Care; 2018 Feb; 48(2):31-39. PubMed ID: 29337001 [TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy and psychotherapy of pediatric depression. Maalouf FT; Brent DA Expert Opin Pharmacother; 2010 Sep; 11(13):2129-40. PubMed ID: 20707755 [TBL] [Abstract][Full Text] [Related]
8. Drugs for depression and bipolar disorder. Treat Guidel Med Lett; 2010 May; 8(93):35-42. PubMed ID: 20414177 [No Abstract] [Full Text] [Related]
9. Current approaches to the psychopharmacologic treatment of depression in children and adolescents. Laraia MT J Child Adolesc Psychiatr Nurs; 1996; 9(1):15-26. PubMed ID: 8696656 [TBL] [Abstract][Full Text] [Related]
11. Evidence-based guidelines for interpretation of the Hamilton Rating Scale for Depression. Furukawa TA; Akechi T; Azuma H; Okuyama T; Higuchi T J Clin Psychopharmacol; 2007 Oct; 27(5):531-4. PubMed ID: 17873700 [No Abstract] [Full Text] [Related]
12. [Treatment of depression with melitracen]. Puzyński S; Kalinowski A Wiad Lek; 1967 Oct; 20(20):1859-64. PubMed ID: 4868392 [No Abstract] [Full Text] [Related]
13. Psychopharmacology of depression in children and adolescents. Smiga SM; Elliott GR Pediatr Clin North Am; 2011 Feb; 58(1):155-71, xi. PubMed ID: 21281854 [TBL] [Abstract][Full Text] [Related]
14. Major depressive disorder. Schechter LE Curr Pharm Des; 2005; 11(2):143-4. PubMed ID: 15638754 [No Abstract] [Full Text] [Related]
15. [Psychopharmacology and psychiatric nosography]. Borgna E Riv Sper Freniatr Med Leg Alien Ment; 1968 Aug; 92(4):1026-67. PubMed ID: 5738058 [No Abstract] [Full Text] [Related]
16. Confounding influence of extraneous symptoms on clinical global impression ratings for depression. Targum SD; Busner J; Dunn J J Clin Psychopharmacol; 2008 Oct; 28(5):587-9. PubMed ID: 18794667 [No Abstract] [Full Text] [Related]
19. Routine treatment of adult depression. Olfson M; Tanielian TL; Peterson BD; Zarin DA Psychiatr Serv; 1998 Mar; 49(3):299. PubMed ID: 9525787 [No Abstract] [Full Text] [Related]
20. [A therapeutic study of sidnocarb tablets]. Kleĭn M; Sobor A Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(2):275-8. PubMed ID: 1119269 [No Abstract] [Full Text] [Related] [Next] [New Search]